Foghorn Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.14

-0.06 (-1.43%)

As of Sep 20, 10:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +600.2% upside

Low Target $18.54

Average Target $28.99

High Target $38.99

Current Price $4.14

Current
$4.14

Target
$28.99

$18.54 $28.99 avg $38.99

Scenario Analysis

Bear Case

$18.54

347.8%

Low target

Base Case

$28.99

+600.2%

Avg target

Bull Case

$38.99

+841.8%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$7.61

-45.6% from high

52-Week Low

$3.27

+26.6% from low

Target vs 52W High

$28.99

+280.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%